CURRENT NEWS

• 29.09.2020
  DARPA Awards Inflammatix Up to $1.1 Million to Develop Diagnostic That Predicts COVID-19 Severity Risk
• 29.09.2020
  Neuropore Therapies Licenses Autophagy Modulators to Global Cancer Technology for Treatment of Cancers and Other Life-Threatening Diseases
• 29.09.2020
  Sema4 Announces Collaboration With Janssen on Optimizing Oncology Clinical Trials
• 29.09.2020
  Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test
• 29.09.2020
  Ajinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic
• 29.09.2020
  Windtree Announces FDA Acceptance of IND Application for a Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults With COVID-19
• 29.09.2020
  ProterixBio Announces Commercial Availability of a Semi-Quantitative COVID-19 Antibody Test
• 29.09.2020
  LifeSci Acquisition Corp. Announces Merger Agreement With Vincera Pharma, Inc. To Create New Publicly Listed Oncology Company
• 29.09.2020
  Paradigm Extends Term, Indications and Territories Under Exclusive Supply Agreement with Bene Pharmachem
• 29.09.2020
  SphingoTec GmbH: SphingoTec, BHR Pharmaceuticals Ink Agreement for Distribution of SphingoTec's Acute Care Portfolio in the UK and Ireland
• 29.09.2020
  CASI Pharmaceuticals Announces Restructuring of Partnership With Juventas Cell Therapy Ltd
• 29.09.2020
  Cepheid Receives Emergency Use Authorization for SARS-CoV-2, Flu A, Flu B and RSV Combination Test
• 29.09.2020
  Polyphor Announces Closing of Fosun Pharma Licensing Agreement for Balixafortide in China and Receipt of $15 Million Upfront Payment
• 29.09.2020
  Doherty Institute Researchers Named Semi Finalists in XPrize Rapid COVID Testing
• 28.09.2020
  VAL201 Clinical Trial Update
• 28.09.2020
  Notification for Acquisition of Own Shares
• 28.09.2020
  Indoco Launches FEVINDO 400 (Favipiravir
• 28.09.2020
  TGen Launches Vidium Animal Health
• 28.09.2020
  Machine Learning and Synthetic Biology Used to Optimize a Cellular Factory for Industrially Relevant Products
• 28.09.2020
  Ansa Biotechnologies Partners with TeselaGen Biotechnology to Enable Commercial Production of DNA Products

Records per page:

Page

Total: 22144 records.